FOXP3 and head and neck cancer: Some studies suggested a negative prognostic value for high frequencies of tumor-infiltrating CD4+CD25+Foxp3+ Tregs in head and neck cancer [3–5], whereas others demonstrated a non-predictive [6] or even positive prognostic role [7–10] for these cells.